Background illustration for clinical trials search

Paid Clinical Trials Hillsboro

Discover 926 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: Portland OR, Seatle WA, Medford OR, Loma Linda CA,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase 3, Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Portland OR, Dallas TX, Houston TX, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase 1, Phase 2, Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Portland OR, Albany OR, Spokane WA, Sacramento CA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase 3, Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Portland OR, Sacramento CA, Palo Alto CA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 6+

Code: NCT07425574

Recruiting

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for
Myopia
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 5 - 11

Code: NCT07095894

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

for
Anterior Uveitis (AU), Birdshot Chorioretinitis, Behcet Disease,
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 5 - 70+

Code: NCT07065747

Recruiting

Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography

for
Cataract
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18+

Code: NCT00532051

Recruiting

Retinoblastoma Patient Clinical Database and Tissue Repository

for
Retinoblastoma, Retinoblastoma Bilateral,
Location: Portland OR, Seattle WA, Los Angeles CA, Phoenix AZ,
Sponsor: Children's Hospital Los Angeles

Sex: All

Age: 0 - 18

Code: NCT04959097

Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Portland OR, Albany OR, Seattle WA, Spokane WA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

for
Corneal Opacity
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18+

Code: NCT01243931

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Portland OR, Reno NV, Walnut Creek CA, Omaha NE,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Portland OR, Seattle WA, Boise ID, Salt Lake City UT,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase 2, Phase 3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Portland OR, Clackamas OR, Kelowna, Vallejo CA,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Portland OR, Eugene OR, Olympia WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for
Breast Carcinoma, Colorectal Carcinoma,
Location: Portland OR, Issaquah WA, Seattle WA, Bellevue WA,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Portland OR, Sacramento CA, San Francisco CA,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting
New

The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease

for
CKD - Chronic Kidney Disease
Location: Portland OR
Sponsor: Kaiser Permanente

Sex: All

Age: 18 - 70+

Code: NCT07857200

Recruiting

Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking

for
Smoking Behaviors
Location: Portland OR
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT07459621

Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Portland OR, Seattle WA, Everett WA, Reno NV,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase 3, Recruiting